Pliant Therapeutics Announces Three Upcoming Presentations At The European Respiratory Society International Congress 2023
Portfolio Pulse from Benzinga Newsdesk
Pliant Therapeutics has announced three presentations at the European Respiratory Society International Congress 2023. The presentations will cover the inhibitor bexotegrast's impact on fibrogenesis in the human lung, its safety and antifibrotic activity from a Phase 2a study, and the elevated levels of circulating ITGB6 in patients with IPF.
August 28, 2023 | 8:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pliant Therapeutics' upcoming presentations at the European Respiratory Society International Congress 2023 could potentially impact the company's stock. The presentations will focus on the company's inhibitor bexotegrast.
The presentations will provide updates on the company's key product, bexotegrast. Positive results or feedback could increase investor confidence and potentially drive the stock price up. However, any negative feedback or results could have the opposite effect.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100